EligibleTrials

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Recruiting · NCT06777368 · Observational (researchers observe without assigning treatment) · Lead sponsor: Medtronic Cardiovascular

View the official record on ClinicalTrials.gov →
Heart failure

Interventions studied

Edwards TAVMedtronic TAV

What this trial is about

The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).

Who can take part

Age range
18 Years to 105 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

60 locations listed across 31 US states.

Showing 60 of 71 listed sites. See the official record for the complete list.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.